ArticleBMC pediatrics2026
Evaluation of serum and cerebrospinal fluid copeptin as biomarkers in children with febrile seizures, febrile illness without seizures, and meningitis: an exploratory study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to compare serum and cerebrospinal fluid (CSF) copeptin levels among children with febrile seizures, febrile illness without seizures, and meningitis; to investigate the relationship between serum and CSF copeptin levels; and to assess the potential diagnostic utility of these biomarkers.
methodsThis study included children aged 1 month to 18 years who presented to the pediatric emergency department with fever or seizures and underwent lumbar puncture because of signs of meningeal irritation or the absence of an identifiable source of fever. The patients were classified into three groups: the Meningitis Group, the Febrile Illness Without Seizures Group, and the Febrile Seizure Group. In addition, a control group consisting of healthy children was included. Serum and CSF copeptin levels were measured in the patient groups, whereas only serum copeptin levels were measured in the control group.
resultsSerum copeptin levels were significantly higher in the Febrile Seizure Group than in both the Febrile Illness Without Seizures Group and the Control Group. Univariate linear regression analysis demonstrated a weak but statistically significant positive association between serum and CSF copeptin levels (p = 0.040), indicating that CSF copeptin levels could be estimated from serum copeptin levels using the following formula: CSF copeptin level = 2.02 + 0.05 × serum copeptin level. In multivariable linear regression analysis, C-reactive protein (CRP) and CSF glucose levels were identified as independent predictors of CSF copeptin levels, irrespective of age and sex (p = 0.009 and p = 0.004, respectively). CSF copeptin measurement was not superior to serum copeptin measurement for distinguishing children with febrile seizures, or children with febrile seizures and/or meningitis, from those with febrile illness without seizures.
conclusionSerum copeptin levels were higher in children with febrile seizures than in those with febrile illness without seizures and in healthy controls. However, because of the very small meningitis sample size, the meningitis-related findings should be considered exploratory and interpreted with caution. Larger prospective studies are required to determine whether copeptin has clinically meaningful utility in distinguishing febrile seizures from meningitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.